Extracellular vesicles in pancreatic cancer progression and therapies

Pancreatic cancer (PC) is one of the leading causes of cancer-related death worldwide due to delayed diagnosis and limited treatments. More than 90% of all pancreatic cancers are pancreatic ductal adenocarcinoma (PDAC). Extensive communication between tumour cells and other cell types in the tumour...

Full description

Bibliographic Details
Main Authors: Chang, C-H, Pauklin, S
Format: Journal article
Language:English
Published: Springer Nature 2021
_version_ 1797073122368684032
author Chang, C-H
Pauklin, S
author_facet Chang, C-H
Pauklin, S
author_sort Chang, C-H
collection OXFORD
description Pancreatic cancer (PC) is one of the leading causes of cancer-related death worldwide due to delayed diagnosis and limited treatments. More than 90% of all pancreatic cancers are pancreatic ductal adenocarcinoma (PDAC). Extensive communication between tumour cells and other cell types in the tumour microenvironment have been identified which regulate cancer hallmarks during pancreatic tumorigenesis via secretory factors and extracellular vesicles (EVs). The EV-capsuled factors not only facilitate tumour growth locally, but also enter circulation and reach distant organs to construct a pre-metastatic niche. In this review, we delineate the key factors in pancreatic ductal adenocarcinoma derived EVs that mediate different tumour processes. Also, we highlight the factors that are related to the crosstalk with cancer stem cells/cancer-initiating cells (CSC/CIC), the subpopulation of cancer cells that can efficiently metastasize and resist currently used chemotherapies. Lastly, we discuss the potential of EV-capsuled factors in early diagnosis and antitumour therapeutic strategies.
first_indexed 2024-03-06T23:17:30Z
format Journal article
id oxford-uuid:67a028d6-db6b-4198-be2f-9d2f28096c0c
institution University of Oxford
language English
last_indexed 2024-03-06T23:17:30Z
publishDate 2021
publisher Springer Nature
record_format dspace
spelling oxford-uuid:67a028d6-db6b-4198-be2f-9d2f28096c0c2022-03-26T18:39:33ZExtracellular vesicles in pancreatic cancer progression and therapiesJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:67a028d6-db6b-4198-be2f-9d2f28096c0cEnglishSymplectic ElementsSpringer Nature2021Chang, C-HPauklin, SPancreatic cancer (PC) is one of the leading causes of cancer-related death worldwide due to delayed diagnosis and limited treatments. More than 90% of all pancreatic cancers are pancreatic ductal adenocarcinoma (PDAC). Extensive communication between tumour cells and other cell types in the tumour microenvironment have been identified which regulate cancer hallmarks during pancreatic tumorigenesis via secretory factors and extracellular vesicles (EVs). The EV-capsuled factors not only facilitate tumour growth locally, but also enter circulation and reach distant organs to construct a pre-metastatic niche. In this review, we delineate the key factors in pancreatic ductal adenocarcinoma derived EVs that mediate different tumour processes. Also, we highlight the factors that are related to the crosstalk with cancer stem cells/cancer-initiating cells (CSC/CIC), the subpopulation of cancer cells that can efficiently metastasize and resist currently used chemotherapies. Lastly, we discuss the potential of EV-capsuled factors in early diagnosis and antitumour therapeutic strategies.
spellingShingle Chang, C-H
Pauklin, S
Extracellular vesicles in pancreatic cancer progression and therapies
title Extracellular vesicles in pancreatic cancer progression and therapies
title_full Extracellular vesicles in pancreatic cancer progression and therapies
title_fullStr Extracellular vesicles in pancreatic cancer progression and therapies
title_full_unstemmed Extracellular vesicles in pancreatic cancer progression and therapies
title_short Extracellular vesicles in pancreatic cancer progression and therapies
title_sort extracellular vesicles in pancreatic cancer progression and therapies
work_keys_str_mv AT changch extracellularvesiclesinpancreaticcancerprogressionandtherapies
AT pauklins extracellularvesiclesinpancreaticcancerprogressionandtherapies